Английская Википедия:Foretinib

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Chembox

Foretinib is an experimental drug candidate for the treatment of cancer.[1] It was discovered by Exelixis and is under development by GlaxoSmithKline.[2] About 10 Phase II clinical trials have been run.[3] Шаблон:As of it appears development has been discontinued.[4]

Foretinib is an inhibitor of the kinase enzymes c-Met and vascular endothelial growth factor receptor 2 (VEGFR-2).[5]

See also

References

Шаблон:Reflist

Шаблон:Growth factor receptor modulators